Skip to content

Intralipid postconditioning in patients undergoing cardiopulmonary bypass:a large sample randomized controlled trial

Intralipid postconditioning in patients undergoing cardiopulmonary bypass:a large sample randomized controlled trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900024387
Enrollment
Unknown
Registered
2019-07-09
Start date
2019-07-01
Completion date
Unknown
Last updated
2019-07-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac surgery under cardiopulmonary bypass

Interventions

Control group:patients in the control group received an intravenous infusion of 2mL/kg of normal saline just 10 min before aortic cross-unclamping
Experimental group:patients in the experimental group received an intravenous infusion of 2mL/kg of 20% intralipid just 10 min before aortic cross-unclamping

Sponsors

Departement of Anesthesiology, West China Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Adult patients undergoing cardiopulmonary bypass in our hospital were eligible for participation if they met the following criteria: 1) there is written informed consent; 2) aged 18 to 70 years; 3) undergoing elective cardiac surgery under CPB; 4) ASA I - III level.

Exclusion criteria

Exclusion criteria: 1) LVEF < 30%; 2) redo cardiac surgery; 3) severe hepatic disfunction; 4) severe renal disease; 5) severe lung disease (or oxygenation index <120); 6) severe coagulation dysfunction; 7) severe hyperlipidemia; 8) any disorder associated with immunological disfunction (eg, malignancy or positive serological test for the HIV); 9) current infections; 10) aortic dissection; 11) preoperative treatment with nicorandil, sulfonylurea 12) preoperative treatment with intralipid in the last 1 month; 13) participating in other clinical studies.

Design outcomes

Primary

MeasureTime frame
LVEF, LVEDS, LVEDD;CK-MB;BNP;cTNT;mortality rate;severe complications;

Secondary

MeasureTime frame
mortality rate;survival quality;awake time;extubation time;length of stay in hospital;length of stay in intensive care unit;all-in cost of stay in hospital;

Countries

China

Contacts

Public ContactRonghua Zhou

Departement of Anesthesiology, West China Hospital

wr.zhou@hotmail.com+86 18980601935

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 25, 2026